What is the appropriate workup and treatment for iron‑deficiency anemia presenting with low ferritin, low serum iron, low transferrin saturation, and low mean corpuscular hemoglobin?

Iron Deficiency Anemia with Low Ferritin, Low Iron Saturation, Low Serum Iron, and Low MCH

Start oral iron supplementation immediately (ferrous sulfate 325 mg daily or every other day) while simultaneously investigating the underlying cause of blood loss or malabsorption 1, 2.

Diagnostic Confirmation

Your laboratory findings confirm iron deficiency anemia:

• Low ferritin (<30-45 ng/mL) is the gold standard for diagnosing iron deficiency 1, 2
• Low transferrin saturation (<20%) confirms inadequate iron availability 3, 2
• Low MCH indicates microcytic, hypochromic red blood cells characteristic of iron deficiency

The 2024 AGA guideline recommends a ferritin cutoff of 45 ng/mL for optimal sensitivity and specificity in anemic patients 1. If inflammation is present (check CRP), ferritin up to 100 ng/mL may still indicate iron deficiency 1, 3.

Mandatory Workup to Find the Source

Immediate Investigations Required:

For all patients:

• Test for Helicobacter pylori infection (common cause of iron malabsorption) 1, 4
• Screen for celiac disease with tissue transglutaminase antibodies 1, 4
• Assess dietary iron intake 1

For premenopausal women:

• Evaluate menstrual blood loss patterns 1, 2
• If heavy menstrual bleeding explains the deficiency and patient is young with no alarm symptoms, treat the bleeding source and provide iron supplementation 4

For men and postmenopausal women:

• Bidirectional endoscopy (upper and lower GI) is mandatory to exclude gastrointestinal bleeding or malignancy 3, 4
• Approximately 94% of cases result from recurrent blood loss 4
• Do not delay endoscopy—occult GI bleeding is the presumed cause until proven otherwise

Treatment Algorithm

First-Line: Oral Iron

Dosing:

• Ferrous sulfate 325 mg daily OR every-other-day dosing (alternate-day dosing improves absorption and reduces side effects) 1, 2, 4
• Other ferrous salts (ferrous fumarate, ferrous gluconate) are equally effective 1
• Target: 28-50 mg elemental iron per dose 5

Optimization tips:

• Take on empty stomach for best absorption 1
• If not tolerated, take with meals (slightly reduced absorption but better compliance) 1
• Add 500 mg vitamin C to enhance absorption 1
• Taking with meat protein improves absorption 1

Common pitfall: Approximately 50% of patients have poor adherence due to GI side effects (nausea, constipation, abdominal pain) 1, 4. Every-other-day dosing significantly improves tolerance 4.

When to Use Intravenous Iron Instead

Immediate IV iron is indicated for:

• Severe anemia requiring rapid correction 2, 6
• Oral iron intolerance or failure after 4-8 weeks 2, 4
• Malabsorption conditions (celiac disease, post-bariatric surgery, atrophic gastritis) 1, 2
• Chronic inflammatory conditions (IBD, CKD, heart failure) where oral absorption is impaired 3, 2
• Ongoing blood loss that exceeds oral replacement capacity 2
• Second and third trimesters of pregnancy 2
• Heart failure patients with iron deficiency (improves exercise capacity and has prognostic benefit) 3, 2

IV iron formulations: Iron dextran, iron gluconate, or iron sucrose are available; hypersensitivity reactions are rare (<1%) with newer formulations 4.

Monitoring Response

Reassess in 2-4 weeks:

• Check hemoglobin and reticulocyte count 4
• Expected response: hemoglobin increase of 1-2 g/dL within 3-4 weeks

If no response after 4 weeks:

• Switch to IV iron 2, 4
• Reconsider diagnosis—may have concurrent B12/folate deficiency, anemia of chronic disease, or other pathology 7
• Consider hematology referral if diagnosis unclear 1, 7

Long-term follow-up:

• Repeat ferritin after 8-10 weeks to confirm iron store repletion 5
• For patients with recurrent deficiency, consider intermittent oral supplementation 5
• Repeat iron studies every 6-12 months in high-risk patients 5

Critical Caveat

Never assume the cause without investigation. In men and postmenopausal women, iron deficiency anemia is gastrointestinal malignancy until proven otherwise—endoscopy is non-negotiable 3, 4. Even in younger women with apparent menstrual losses, if symptoms persist despite treatment or alarm features exist, proceed with GI evaluation 4.